1. Home
  2. IMUX vs LSBK Comparison

IMUX vs LSBK Comparison

Compare IMUX & LSBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMUX
  • LSBK
  • Stock Information
  • Founded
  • IMUX 2016
  • LSBK 1891
  • Country
  • IMUX United States
  • LSBK United States
  • Employees
  • IMUX N/A
  • LSBK N/A
  • Industry
  • IMUX Biotechnology: Pharmaceutical Preparations
  • LSBK Savings Institutions
  • Sector
  • IMUX Health Care
  • LSBK Finance
  • Exchange
  • IMUX Nasdaq
  • LSBK Nasdaq
  • Market Cap
  • IMUX 86.3M
  • LSBK 91.1M
  • IPO Year
  • IMUX N/A
  • LSBK 2006
  • Fundamental
  • Price
  • IMUX $1.01
  • LSBK $15.80
  • Analyst Decision
  • IMUX Strong Buy
  • LSBK
  • Analyst Count
  • IMUX 6
  • LSBK 0
  • Target Price
  • IMUX $12.67
  • LSBK N/A
  • AVG Volume (30 Days)
  • IMUX 895.5K
  • LSBK 3.4K
  • Earning Date
  • IMUX 02-24-2025
  • LSBK 01-24-2025
  • Dividend Yield
  • IMUX N/A
  • LSBK 3.38%
  • EPS Growth
  • IMUX N/A
  • LSBK 7.32
  • EPS
  • IMUX N/A
  • LSBK 0.88
  • Revenue
  • IMUX N/A
  • LSBK $25,846,000.00
  • Revenue This Year
  • IMUX N/A
  • LSBK N/A
  • Revenue Next Year
  • IMUX N/A
  • LSBK N/A
  • P/E Ratio
  • IMUX N/A
  • LSBK $17.98
  • Revenue Growth
  • IMUX N/A
  • LSBK N/A
  • 52 Week Low
  • IMUX $0.92
  • LSBK $10.30
  • 52 Week High
  • IMUX $2.11
  • LSBK $16.56
  • Technical
  • Relative Strength Index (RSI)
  • IMUX 53.58
  • LSBK 71.76
  • Support Level
  • IMUX $0.92
  • LSBK $15.45
  • Resistance Level
  • IMUX $0.97
  • LSBK $15.78
  • Average True Range (ATR)
  • IMUX 0.06
  • LSBK 0.33
  • MACD
  • IMUX 0.01
  • LSBK 0.12
  • Stochastic Oscillator
  • IMUX 85.08
  • LSBK 100.00

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.

About LSBK Lake Shore Bancorp Inc.

Lake Shore Bancorp Inc operates as a savings and loan holdings company. The bank's business consists of attracting retail deposits from the general public in the areas surrounding its branch offices and investing those deposits, together with funds generated from operations, in commercial real estate loans, one-to-four family residential mortgage loans, home equity lines of credit and, to a lesser extent, commercial business loans, consumer loans, and investment securities. Its revenues are principally derived from interest earned on loans and investment securities.

Share on Social Networks: